A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-

NCT02623738 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

253

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Placebo ophthalmic solution
DRUG: DE-117 ophthalmic solution low
DRUG: DE-117 ophthalmic solution high
DRUG: Latanoprost ophthalmic solution 0.005%

Sponsor

Santen Pharmaceutical Co., Ltd.